Ranbaxy has won four patents in Norway. However, the world's largest drugmaker Pfizer says that it will appeal against the ruling.
Ranbaxy has won four Atorvastatin patents in Norway. The Atorvastatin branded Lipitor has a USD 40-50 million market size in Norway.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment